We first derive and validate a novel mitotic clock model called epiTOC2 (Epigenetic Timer of Cancer-2), which, unlike our previous epiTOC model [15], allows direct estimation of the cumulative number of stem cell divisions in a tissue. This evidence concerns the gene CLOCK and cancer.